Compugen (CGEN) Other Non-Current Assets (2009 - 2026)
Compugen (CGEN) posted quarterly Other Non-Current Assets of $1.3 million for Q1 2026, down 20.84% year-over-year from $1.6 million in Q1 2025, and little changed on a QoQ basis from $1.3 million in Q4 2025.
Analysis
Compugen (CGEN) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Compugen has reported Other Non-Current Assets for 18 years, with the latest figure at $1.3 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $1.3 million, down 20.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 20.84% YoY), and the FY2025 annual result was $1.3 million, down 31.51% from the prior year.
- Other Non-Current Assets held at $1.3 million in Q1 2026, from $1.3 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $1.9 million in Q1 2022 and troughed at $922000.0 in Q2 2024.
- A 5-year average of $1.6 million and a median of $1.7 million in 2025 frame the typical range for Other Non-Current Assets.
- The widest annual swing landed in 2024, when Other Non-Current Assets tumbled 51.78%; it then surged 88.5% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $1.9 million in 2022, then plunged by 35.07% to $1.2 million in 2023, then jumped by 53.12% to $1.9 million in 2024, then plunged by 31.51% to $1.3 million in 2025, then advanced by 0.15% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | 1.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 934,000.00 |
| Dec 31, 2023 | 365,000.00 |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 615,000.00 |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 362,000.00 |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 363,000.00 |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 3.13 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 681,000.00 |